Category: Workers Comp

609 posts found

Suzetrigine’s Early Impact for Pain Management

Data presented at PAINWeek 2026 indicates that the novel, non-opioid pain medication may be shaking up prescribing patterns for acute pain.

RxInformer article image of person on a scale

This Month's Must Read

Tipping the Scales? GLP-1 Considerations for Workers’ Comp

Rising GLP-1 use is slowly creeping into claims, requiring a review of clinical considerations.

Clinical Insights

WCRI Publishes Report on Mental Health Claims

Frequency for mental health claims was higher among longer-tenure workers, higher-wage earners, women, and those in clerical and professional occupations.

Legislation & Policy

NCCI Publishes Legislative and Regulatory Trends Report

Trending topics include worker classification, portable benefits, mental injuries, single-payer insurance, marijuana, and psychedelics.

Healthe Developments

Updates from the IAIABC’s 112th Convention

In addition to recapping roundtable discussions, the event saw Sandy Shtab, Healthesystems VP of Industry and State Relations, receive the IAIABC President’s Award.

Medmonitor

Novel Drug Approvals Supported by Fewer Studies

A study from PLOS One examined trends in drug approvals before and after implementation of new federal regulations for evidentiary standards.

This Month's Must Read

Coming Up Short: When Drug Shortages Become a Claims Problem

Shortages can increase costs, delay or alter treatment, increase complexity, and impact claims outcomes.

Legislation & Policy

Alaska Proposes Significant Pharmacy Reimbursement Changes

Impacted drugs include physician-dispensed and repackaged drugs, topicals, compounds, and OTC medications.

Psychedelic Developments

SAMHSA Recommends States Plan for Legal Implications of FDA-Approved Psychedelics

States are encouraged to plan now for the implications of potential psychedelic therapies, including Medicaid coverage obligations.

Healthe Developments

Hidden Comorbidities Complicate Workers Comp Claims

Business Insurance recaps an educational presentation held at WCI 2026, featuring Healthesystems VP of Clinical Services, Silvia Sacalis, PharmD, BS.

Medmonitor

Generic Drug Tariffs Announced for 2028

A 100% tariff will take effect August 1, 2028 for generic drugs imported into the U.S., followed by a 200% tariff in August 2029.

This Month's Must Read

6 Steps for More Effective Pharmacy Workflows

Effective pharmacy workflows pair greater efficiency with better health outcomes, reducing burden for claims professionals while increasing impact.

Industry Insights

WCRI Reports on Trends in Non-Price-Controlled Medical Services

The study focused on DME and professional services billed by nonhospital providers from January 1, 2019 through June 30, 2025.

image of New York state statue of liberty

Legislation & Policy

New York Broadens Pay Without Prejudice Rules

Effective January 1, 2027, payers may voluntarily cover medical treatment for up to one year while compensability determination is under review.

Psychedelic drugs and laboratory imagery

Psychedelic Developments

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th, with written comments accepted until October 5th.

1 2 3 4 5 … 37 38 39 40 41 Next